INMB
INmune Bio (INMB)
$14
About INmune Bio (INMB)
INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. The company was founded by Mark Lowdell on September 25, 2015 and is headquartered in Boca Raton, FL.
Details
Daily high
$2.18
Daily low
$2.08
Price at open
$2.09
52 Week High
$2.53
52 Week Low
$1.09
Market cap
59.1M
Dividend yield
-
Volume
87,982
Avg. volume
335,324
P/E ratio
-3.08
INmune Bio News
Details
Daily high
$2.18
Daily low
$2.08
Price at open
$2.09
52 Week High
$2.53
52 Week Low
$1.09
Market cap
59.1M
Dividend yield
-
Volume
87,982
Avg. volume
335,324
P/E ratio
-3.08